Posted On: 11/16/2015 9:45 AM
Trumpet– A registry of prostate cancer patients
1. Male age 18 or over
2. Scheduled to start first medication for resistant prostate cancer
Sponsored by: Astellas
Length of Study: 7 years
Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.
Research Department (315) 478-4185, option 7
Our Investigator for this study is Christopher Pieczonka, M.D.